YC, C., ML, H., HL, L., SW, H., CF, C., HY, Y., . . . LM, C. (2025). Author Correction: Identification of PTGR2 inhibitors as a new therapeutic strategy for diabetes and obesity. EMBO molecular medicine, 17(5), 1184. https://doi.org/10.1038/s44321-025-00228-0
Chicago Style (17th ed.) CitationYC, Chang, et al. "Author Correction: Identification of PTGR2 Inhibitors as a New Therapeutic Strategy for Diabetes and Obesity." EMBO Molecular Medicine 17, no. 5 (2025): 1184. https://doi.org/10.1038/s44321-025-00228-0.
MLA (9th ed.) CitationYC, Chang, et al. "Author Correction: Identification of PTGR2 Inhibitors as a New Therapeutic Strategy for Diabetes and Obesity." EMBO Molecular Medicine, vol. 17, no. 5, 2025, p. 1184, https://doi.org/10.1038/s44321-025-00228-0.